Amniocell Therapeutics is categorized under Biological Products Manufacturers in Chapel Hill, NC and active since 2009.
Amniocell Therapeutics was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Sheila Mikhail at the company’s single location by writing to 870 Martin Luther King Jr, Chapel Hill, North Carolina NC 27514 or by phoning (919) 933-4990. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amniocell Therapeutics |
| Contact Person: | Sheila Mikhail |
| Address: | 870 Martin Luther King Jr, Chapel Hill, North Carolina 27514 |
| Phone Number: | (919) 933-4990 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Amniocell Therapeutics was started in 2009 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Sheila Mikhail for inquiries that concern Amniocell Therapeutics by calling the company number (919) 933-4990, as your correspondence is most welcome. Additionally, the physical location of the single location of Amniocell Therapeutics can be found at the coordinates 35.928602,-79.054539 as well as the street address 870 Martin Luther King Jr in Chapel Hill, North Carolina 27514.
For its online presence, you may visit Amniocell Therapeutics’s website at and engage with its social media outlets through on Twitter and on Facebook.